Glenmark Pharmaceuticals Limited (GLENMARK.BO)
INR 1541.0
(1.1%)
INR 1541.0
(1.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.5 Billion INR | -64.17% |
| 2022 | 17.12 Billion INR | -9.04% |
| 2021 | 18.82 Billion INR | 13.05% |
| 2020 | 16.65 Billion INR | 37.08% |
| 2019 | 12.14 Billion INR | -23.6% |
| 2018 | 15.89 Billion INR | 18.34% |
| 2017 | 13.43 Billion INR | -9.19% |
| 2016 | 14.79 Billion INR | 25.79% |
| 2015 | 11.76 Billion INR | 50.2% |
| 2014 | 7.83 Billion INR | -10.9% |
| 2013 | 8.78 Billion INR | -1.78% |
| 2012 | 8.94 Billion INR | 42.99% |
| 2011 | 6.25 Billion INR | -1.94% |
| 2010 | 6.38 Billion INR | 16.46% |
| 2009 | 5.47 Billion INR | 4.11% |
| 2008 | 5.26 Billion INR | -26.03% |
| 2007 | 7.11 Billion INR | 96.92% |
| 2006 | 3.61 Billion INR | 222.4% |
| 2005 | 1.12 Billion INR | -11.96% |
| 2004 | 1.27 Billion INR | 147.54% |
| 2003 | 514.23 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 4.7 Billion INR | 33.26% |
| 2023 FY | 6.13 Billion INR | -64.17% |
| 2023 Q4 | 3.53 Billion INR | 213.76% |
| 2023 Q1 | 4.76 Billion INR | 3.95% |
| 2023 Q2 | 3.2 Billion INR | -32.68% |
| 2023 Q3 | -3.1 Billion INR | -196.72% |
| 2022 Q4 | 4.58 Billion INR | 0.1% |
| 2022 Q3 | 4.57 Billion INR | -1.69% |
| 2022 Q2 | 4.65 Billion INR | 63.55% |
| 2022 FY | 17.12 Billion INR | -9.04% |
| 2022 Q1 | 2.84 Billion INR | -14.17% |
| 2021 Q3 | 5.74 Billion INR | 22.97% |
| 2021 Q2 | 4.66 Billion INR | 1.41% |
| 2021 Q1 | 4.6 Billion INR | 11.68% |
| 2021 Q4 | 3.31 Billion INR | -42.2% |
| 2021 FY | 18.82 Billion INR | 13.05% |
| 2020 Q1 | 4.23 Billion INR | 10.04% |
| 2020 FY | 16.65 Billion INR | 37.08% |
| 2020 Q2 | 4.16 Billion INR | -1.53% |
| 2020 Q3 | 4.29 Billion INR | 3.14% |
| 2020 Q4 | 4.12 Billion INR | -4.1% |
| 2019 Q3 | 3.67 Billion INR | -16.02% |
| 2019 Q4 | 3.84 Billion INR | 4.82% |
| 2019 FY | 12.14 Billion INR | -23.6% |
| 2019 Q1 | 2.52 Billion INR | 83.91% |
| 2019 Q2 | 4.37 Billion INR | 72.86% |
| 2018 FY | 15.89 Billion INR | 18.34% |
| 2018 Q1 | 4.05 Billion INR | 32.27% |
| 2018 Q3 | 2.42 Billion INR | -51.25% |
| 2018 Q2 | 4.97 Billion INR | 22.63% |
| 2018 Q4 | 1.37 Billion INR | -43.32% |
| 2017 Q3 | 2.1 Billion INR | -36.49% |
| 2017 FY | 13.43 Billion INR | -9.19% |
| 2017 Q4 | 3.06 Billion INR | 46.06% |
| 2017 Q2 | 3.3 Billion INR | -35.79% |
| 2017 Q1 | 5.15 Billion INR | 67.19% |
| 2016 Q2 | 3.69 Billion INR | -2.32% |
| 2016 Q3 | 7 Billion INR | 89.45% |
| 2016 FY | 14.79 Billion INR | 25.79% |
| 2016 Q4 | 3.08 Billion INR | -56.04% |
| 2016 Q1 | 3.78 Billion INR | 60.93% |
| 2015 FY | 11.76 Billion INR | 50.2% |
| 2015 Q2 | 3.33 Billion INR | 8.93% |
| 2015 Q3 | 3.09 Billion INR | -7.2% |
| 2015 Q4 | 2.35 Billion INR | -23.91% |
| 2015 Q1 | 3.05 Billion INR | 40.8% |
| 2014 Q1 | 2.8 Billion INR | 206.1% |
| 2014 FY | 7.83 Billion INR | -10.9% |
| 2014 Q4 | 2.17 Billion INR | 7.38% |
| 2014 Q3 | 2.02 Billion INR | -25.39% |
| 2014 Q2 | 2.71 Billion INR | -3.4% |
| 2013 Q4 | 917.12 Million INR | -70.32% |
| 2013 FY | 8.78 Billion INR | -1.78% |
| 2013 Q2 | 2.68 Billion INR | 24.19% |
| 2013 Q1 | 2.16 Billion INR | -0.8% |
| 2013 Q3 | 3.08 Billion INR | 15.04% |
| 2012 Q3 | 2.89 Billion INR | 17.84% |
| 2012 Q4 | 2.17 Billion INR | -24.74% |
| 2012 FY | 8.94 Billion INR | 42.99% |
| 2012 Q1 | 1.4 Billion INR | -28.4% |
| 2012 Q2 | 2.45 Billion INR | 75.27% |
| 2011 Q4 | 1.95 Billion INR | 116.52% |
| 2011 FY | 6.25 Billion INR | -1.94% |
| 2011 Q3 | 904.7 Million INR | 0.0% |
| 2010 FY | 6.38 Billion INR | 16.46% |
| 2009 FY | 5.47 Billion INR | 4.11% |
| 2008 FY | 5.26 Billion INR | -26.03% |
| 2007 FY | 7.11 Billion INR | 96.92% |
| 2006 FY | 3.61 Billion INR | 222.4% |
| 2005 FY | 1.12 Billion INR | -11.96% |
| 2004 FY | 1.27 Billion INR | 147.54% |
| 2003 FY | 514.23 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 66.955% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -1321.149% |
| Sigachi Industries Limited | 1.47 Billion INR | -341.17% |
| Bal Pharma Limited | 233.9 Million INR | -2679.876% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -47.094% |
| Medico Remedies Limited | 100.3 Million INR | -6382.931% |
| Lasa Supergenerics Limited | -458 Million INR | 1519.718% |
| Venus Remedies Limited | 534.65 Million INR | -1116.191% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 258.015% |
| Alpa Laboratories Limited | 184.49 Million INR | -3424.383% |
| Nectar Lifesciences Limited | 923.8 Million INR | -603.869% |
| Shilpa Medicare Limited | 1.36 Billion INR | -375.921% |
| Aarti Drugs Limited | 7.14 Billion INR | 9.041% |
| Lupin Limited | 28.04 Billion INR | 76.814% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 84.593% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 84.916% |
| Windlas Biotech Limited | 1.29 Billion INR | -400.611% |
| Suven Life Sciences Limited | -1.22 Billion INR | 630.451% |
| Eris Lifesciences Limited | 5.18 Billion INR | -25.487% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 54.474% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 268.766% |
| Ipca Laboratories Limited | 7.98 Billion INR | 18.523% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -428.219% |
| Achyut Healthcare Limited | 4.43 Million INR | -146415.998% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 93.766% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | -183.662% |
| Mankind Pharma Limited | 21.51 Billion INR | 69.782% |
| Laurus Labs Limited | 3.94 Billion INR | -64.676% |
| Piramal Pharma Limited | 4.55 Billion INR | -42.693% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2508.768% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 74.335% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -12.926% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -937.89% |
| Wanbury Limited | 569.71 Million INR | -1041.337% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -41.122% |
| Wockhardt Limited | -670 Million INR | 1070.504% |
| Themis Medicare Limited | 392.58 Million INR | -1556.282% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -1179.669% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -25.311% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 27.584% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 90.399% |
| Divi's Laboratories Limited | 33.08 Billion INR | 80.343% |
| NATCO Pharma Limited | 25.96 Billion INR | 74.954% |
| Gufic Biosciences Limited | 1.32 Billion INR | -388.934% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -307.213% |
| Ind-Swift Limited | 1.22 Billion INR | -430.389% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -133.395% |
| FDC Limited | 2.98 Billion INR | -117.747% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 4379.092% |
| Granules India Limited | 6.81 Billion INR | 4.611% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 66.589% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -278.596% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -71601.346% |
| Brooks Laboratories Limited | 14.44 Million INR | -44930.332% |
| Megasoft Limited | -121.1 Million INR | 5469.253% |
| ZIM Laboratories Limited | 253.82 Million INR | -2461.717% |
| Strides Pharma Science Limited | 5.22 Billion INR | -24.428% |
| Neuland Laboratories Limited | 5.31 Billion INR | -22.269% |
| Morepen Laboratories Limited | 4.17 Billion INR | -55.789% |
| Hikal Limited | 32.11 Million INR | -20150.327% |
| Indoco Remedies Limited | 1.29 Billion INR | -403.066% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -107.869% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3025.393% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -23581.186% |
| Hester Biosciences Limited | 364.81 Million INR | -1682.402% |